Call
+918447748545

Published on: Apr 04, 2020
2 minute read
By: Dr Rajan Choudhary

THE CHALLENGES FACED IN MAKING A VACCINE FOR COVID-19 — Part 2

Previously we’ve seen the difficulties researches face in trying to make a vaccine. But even if we make a vaccine, that’s just half the battle. Viruses are unique because they can mutate, and they can mutate to astonishing degrees. In humans mutations to tiny parts of our DNA can cause severe diseases or even death. In viruses mutations can change their structure, making them more infective and giving them a new coat. It gives them a survival advantage, the ability to evade our immune system and make our vaccines ineffective. This is why we need a new flu vaccine every year.

If it takes months to a year to develop a vaccine, it will be based off the virus found in December 2019. By this time the virus may have spread and mutated to such a degree that it is not effective. This does not mean all the effort was for nothing. Going through the steps and understanding the issues faced with making a COVID-19 vaccine can make the process quicker for subsequent vaccines against its mutated versions.

https://www.sciencealert.com/who-says-a-coronavirus-vaccine-is-18-months-away So Long to Develop a Vaccine

FAILURES FROM THE PAST

These issues were faced during the Ebola and Zika virus epidemics, and many large companies are understandably hesitant to develop vaccines for COVID-19. Ebola first broke out in 2014, and it was only in December 2019 that the first vaccine was approved for use by the European Commission and the United States. This is despite multiple large institutes in Canada and the UK working together to develop it.

13 different Ebola vaccine candidates had been identified soon after the outbreak, but none had been tested on humans. Unfortunately this is the most expensive part of development, and the area biopharmecuticals stand to loose the most money. Return on investments is also low, since epidemics usually take place in poorer countries, and the potential customers are unable to pay the high prices for these brand new treatments. It is an unfortunate realisation that research into medicines is driven by rich countries, for diseases that affect the rich.

https://newint.org/features/web-exclusive/2016/06/16/why-did-the-market-fail-to-produce-an-ebola-vaccine Ebola

WHERE ARE WE NOW?

This is all well and good, but what does it mean for COVID-19? We know we cannot rush a vaccine, because a poorly designed vaccine with unknown side effects can cause more harm than good, especially if given to children or the elderly. Currently the WHO are tracking 31 different attempts at making a COVID-19 vaccine, using different methods as discussed before. All of these are currently in the pre-clinical stage, focusing on isolating parts of the virus and creating a target the body will recognise and react to.

Researchers at the University of Queensland were one of the first to start using the genetic code of COVID-19, released openly by Chinese researchers. They have developed a test vaccine within 6 weeks using state-of-the-art genetic techniques, used for the first time. If animal models prove successful then human testing might begin within 6 months. In the pharmaceutical industry advancements this quick are almost unheard of.

Additionally over 293 clinical trials are taking place in China using existing drugs on the market. The advantage is we already know these drugs are safe to use in humans, but we are trying to work out if they will work against COVID-19. Some scientists are also looking at medications that were initially developed against SARS and MERS, but never completed because these outbreaks died down and the medication was no longer required.

https://www.aljazeera.com/news/2020/03/china-recovered-develop-effective-covid-19-treatments-200302082850237.html COVID-19 treatments

https://www.who.int/blueprint/priority-diseases/key-action/novel-coronavirus-landscape-ncov.pdf?ua=1 WHO news

https://www.theverge.com/2020/2/28/21156385/covid-coronavirus-vaccine-treatment-moderna-remdesivir-research COVID-19 treatment

Its not all doom and gloom. Challenges drive innovation, and we are already benefitting from this. New forms of genetic sequencing, new methods for extracting viral proteins, new techniques in creating a vaccine. These innovations are already benefitting us on the drive to create an effective vaccine for COVID-19, and they will benefit us in the future when the next pandemic hits.

Dr Rajan Choudhary, Product Manager Second Medic UK

www.secondmedic.com

Read Blog

Secondmedic Lunch & Learns: How Combining Skill Building and Health Education Transforms Workplace Wellness

Corporate wellness is no longer limited to annual health checkups or fitness challenges. Modern organisations recognise that sustained employee wellbeing requires continuous learning, awareness and engagement. Secondmedic Lunch & Learns are designed around this philosophy, bringing together skill development and health education in a format that is practical, engaging and easy to implement.

By using informal lunchtime sessions, organisations create a safe, relaxed environment where employees can learn, ask questions and apply knowledge immediately.

What Are Lunch & Learn Sessions?

Lunch & Learn sessions are short, focused learning programs conducted during lunch hours.

They:

minimise disruption to work
encourage voluntary participation
promote informal learning

Secondmedic enhances this format by integrating health education with essential workplace skills.

Why Combine Skill Development with Health Education?

Health and performance are deeply interconnected.

Employees who understand:

stress management
nutrition
ergonomics
mental wellbeing

are better equipped to:

focus
collaborate
perform consistently

NITI Aayog workforce reports highlight that health literacy directly influences productivity and engagement.

The Growing Need for Workplace Health Education in India

India faces a rising burden of lifestyle diseases.

According to ICMR and NFHS-5:

a large portion of the working population has undiagnosed risk factors
stress and sedentary behaviour are increasing
health awareness remains low despite access to information

Workplaces offer the ideal platform for preventive health education.

How Secondmedic Lunch & Learns Are Structured

Secondmedic Lunch & Learns follow a structured yet flexible format:

short expert-led presentations
interactive discussions
real-life case examples
practical takeaways

Sessions are designed to be concise, engaging and actionable.

Health Topics Commonly Covered

Health education topics include:

preventive health and early detection
stress and mental wellbeing
nutrition for working professionals
sleep health and fatigue management
posture and ergonomic safety

These topics address everyday challenges faced by employees.

Skill-Focused Learning Areas

Alongside health, sessions also support professional growth through:

communication skills
time and energy management
resilience and adaptability
decision-making under pressure

This dual focus enhances overall workplace capability.

Benefits for Employees

Improved Health Awareness

Employees learn how daily habits affect long-term health.

Practical Skill Application

Skills taught can be used immediately at work and home.

Higher Engagement

Interactive sessions increase participation and interest.

Reduced Stress

Knowledge empowers employees to manage stress better.

Benefits for Employers

Stronger Wellness Culture

Learning-driven wellness signals genuine organisational care.

Better Productivity

Healthy, skilled employees perform more consistently.

Reduced Absenteeism

Preventive education lowers illness-related leave.

High ROI Initiative

Lunch & Learns are cost-effective and scalable.

EY-FICCI reports show that preventive wellness programs deliver long-term savings for organisations.

Why Lunch Hours Work Best

Lunchtime sessions:

feel informal and relaxed
encourage open participation
avoid meeting fatigue

Employees are more receptive when learning is integrated naturally into the day.

Virtual and Hybrid Lunch & Learns

Secondmedic adapts sessions for:

in-office teams
remote employees
hybrid workplaces

This ensures consistent learning experiences across locations.

Role of Medical and Subject Experts

Sessions are led by:

doctors
nutritionists
mental health professionals
trained facilitators

Expert-led content ensures accuracy and trust.

Encouraging Behaviour Change Through Education

Information alone does not drive change.

Secondmedic focuses on:

practical examples
small habit shifts
realistic goal setting

Lancet behaviour change studies confirm that interactive education improves long-term adherence.

Measuring Impact of Lunch & Learns

Organisations often observe:

higher session attendance
improved employee feedback
increased health screening participation
better engagement scores

These metrics demonstrate sustained value.

Aligning Lunch & Learns with Preventive Healthcare

Lunch & Learns complement:

preventive health checkups
wellness campaigns
digital health initiatives

They reinforce messages and encourage proactive health decisions.

Customisation for Organisational Needs

Secondmedic customises sessions based on:

workforce demographics
industry-specific risks
organisational goals

Tailored content improves relevance and impact.

Long-Term Value of Continuous Learning

Wellness is not a one-time intervention.

Regular Lunch & Learns:

reinforce healthy behaviours
build long-term awareness
create a learning culture

WHO emphasises continuous education as a pillar of workplace health promotion.

Conclusion

Secondmedic Lunch & Learns represent a modern, effective approach to corporate wellness by combining skill development with health education. These sessions empower employees with knowledge that improves both personal wellbeing and professional performance. Easy to implement, cost-effective and highly engaging, Lunch & Learns help organisations build healthier, more capable and more loyal teams. When learning and wellbeing come together, workplaces thrive.

References

Indian Council of Medical Research (ICMR) – Workplace Health and Lifestyle Studies
National Family Health Survey (NFHS-5) – Adult Health and Risk Factor Data
World Health Organization (WHO) – Workplace Health Promotion Guidelines
Lancet – Health Education and Behaviour Change Research
NITI Aayog – Workforce Productivity and Preventive Health Reports
EY-FICCI – Corporate Wellness and Employee Engagement Studies

Request A Callback

+91

By using this website/app, I confirm that I am at least 18 years old and consent to the processing of my personal data in accordance with the Terms of Service, Privacy Policy, and Declaration.